Uri Weinberg - Net Worth and Insider Trading

Uri Weinberg Net Worth

The estimated net worth of Uri Weinberg is at least $1 Million dollars as of 2024-05-24. Uri Weinberg is the Chief Science Officer of NovoCure Ltd and owns about 43,286 shares of NovoCure Ltd (NVCR) stock worth over $1 Million. Details can be seen in Uri Weinberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Uri Weinberg has not made any transactions after 2023-01-05 and currently still holds the listed stock(s).

Transaction Summary of Uri Weinberg

To

Uri Weinberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Uri Weinberg owns 1 companies in total, including NovoCure Ltd (NVCR) .

Click here to see the complete history of Uri Weinberg’s form 4 insider trades.

Insider Ownership Summary of Uri Weinberg

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2023-03-03 Chief Innovation Officer

Uri Weinberg Latest Holdings Summary

Uri Weinberg currently owns a total of 1 stock. Uri Weinberg owns 43,286 shares of NovoCure Ltd (NVCR) as of January 5, 2023, with a value of $1 Million.

Latest Holdings of Uri Weinberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2023-01-05 43,286 23.61 1,021,982

Holding Weightings of Uri Weinberg


Uri Weinberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Uri Weinberg has made a total of 5 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in NovoCure Ltd is the sale of 8,143 shares on January 5, 2023, which brought Uri Weinberg around $945,728.

Insider Trading History of Uri Weinberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Uri Weinberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Uri Weinberg Ownership Network

Ownership Network List of Uri Weinberg

No Data

Ownership Network Relation of Uri Weinberg


Uri Weinberg Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

Uri Weinberg is the Chief Innovation Officer of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, Uri Weinberg made 1 insider transaction in NovoCure Ltd (NVCR) with a net sale of 8,143. Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 62,300 shares made by Frank X Leonard , a net sale of 25,323 shares made by Pritesh Shah , and a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen .

In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 352,694 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,694 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

Uri Weinberg Mailing Address

Above is the net worth, insider trading, and ownership report for Uri Weinberg. You might contact Uri Weinberg via mailing address: Novocure Inc., 20 Valley Stream Parkway, Suite 300, Malvern Pa 19355.

Discussions on Uri Weinberg

No discussions yet.